Share this page!

U.S. FDA Profile picture
Twitter logo
May 25 • 10 tweets • 2 min read
False information is circulating on social media stating that COVID-19 vaccines cause monkeypox. That’s just complete nonsense. Here’s the truth…
#FDAVaccineFacts A graphic featuring a vial of COVID-19 vaccine in front of a
NONE of the FDA-approved/authorized COVID-19 vaccines can cause monkeypox. The vaccines will not infect you w/SARS-CoV-2 or the monkeypox virus. They do not contain these viruses.
There are NO vaccines that inject the “genome of a chimpanzee” into cells of the human body.
Pfizer-BioNTech COVID-19 Vaccine/Comirnaty & Moderna COVID-19 Vaccine/Spikevax are made using genetic material (mRNA). They deliver a piece of mRNA that instructs cells in the body to make a copy of the distinctive “spike” protein of SARS-CoV-2, the virus that causes COVID-19.
The result of a person receiving mRNA vaccines is that their immune system will ultimately react defensively to the SARS-CoV-2 virus. The mRNA in is only present in the body for a short time & is not incorporated into - nor does it alter - an individual’s genetic material.
The Janssen COVID-19 Vaccine is made using a viral vector made from a specific human virus called adenovirus type 26 (Ad26). The vaccine uses Ad26 to deliver a piece of the DNA (genetic material) that is used to make the distinctive “spike” protein of the SARS-CoV-2 virus.
While adenoviruses are a group of viruses that are relatively common & can cause cold symptoms & pink eye, the Ad26 vector has been modified so that it can’t replicate in the human body to cause illness.
Jynneos, a vaccine approved by FDA in 2019 for the prevention of smallpox & monkeypox disease in adults 18 years of age & older determined to be at high risk for smallpox or monkeypox infection, does not contain the viruses that cause smallpox or monkeypox.
Jynneos is made from a vaccinia virus, a virus that is closely related to but less harmful than the viruses that cause smallpox (variola virus) or monkeypox & can protect against both of these diseases.
Jynneos contains a modified virus (Modified Vaccinia Ankara), which does not cause disease in humans & is non-replicating, meaning it cannot reproduce in human cells.

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with U.S. FDA

U.S. FDA Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @US_FDA

U.S. FDA Profile picture
May 24
We’re providing an update on steps FDA has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. fda.gov/news-events/pr… Over a blue background, a w...
We’ve informed Kendal Nutricare that the FDA is exercising enforcement discretion for the importation of certain infant formula under the Kendamil brand.
Under the agency’s recent increased flexibilities regarding importation of certain infant formula products, at least 3.2 million cans of infant formula from Kendal Nutricare is expected to land on U.S. store shelves beginning in June.
Read 8 tweets
U.S. FDA Profile picture
May 24
Here’s the latest edition of “FDA Roundup” including guidances on blood establishments, a report on a cooperative agreement, and a marketing approval for a first-of-its-kind product. fda.gov/news-events/pr… Newspaper mockup graphic with image of FDA headquarters in t
Monday, we announced the availability of one final guidance and two draft guidances for blood establishments regarding donor eligibility requirements.
We also announced the availability of a report drafted by Reagan-Udall as part of a cooperative agreement. The report discusses the feasibility of establishing a voluntary public-private partnership to collect & analyze antimicrobial use data. fda.gov/animal-veterin…
Read 5 tweets
U.S. FDA Profile picture
May 23
Today, we are updating some meeting dates of our vaccine advisory committee based on new information from vaccine manufacturers and expected EUA requests. The new dates for our pediatric COVID-19 vaccine meetings will now be June 14 and June 15. fda.gov/news-events/pr… Image
June 14 will be the new meeting date for the FDA and our advisory committee of external experts to discuss Moderna’s EUA request for 6 years through 17 years.
June 15 will be the new meeting date for the Moderna EUA request for 6 months through 5 years & Pfizer-BioNTech EUA request for 6 months through 4 years of age, based on expected completion of an EUA submission.
Read 5 tweets
U.S. FDA Profile picture
Mar 21
Today, we announced a virtual meeting of our Vaccines and Related Biological Products Advisory Committee to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains to address variants. fda.gov/news-events/pr…
The April 6 VRBPAC meeting will include discussions about what might warrant updating the composition of COVID-19 vaccines to address specific variants, as well as any considerations regarding the appropriate timing and populations for booster doses in coming months.
We intend to make background material available to the public, including the meeting agenda and committee roster, no later than two business days before the meeting.
Read 4 tweets
U.S. FDA Profile picture
Feb 1
Today's “FDA Roundup” includes a new video on food allergy safety, a list of food draft guidances, an annual report, and a COVID-19 test safety communication. fda.gov/news-events/pr…
On January 31, we released a new video that provides an overview of the 2021 Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. The FASTER Act adds sesame to the list of major food allergens effective January 1, 2023.
Yesterday, @FDAFood released a list of draft and final guidance topics that are a priority for the FDA Foods Program to complete during the next 12 months.
Read 7 tweets
U.S. FDA Profile picture
Jan 31
Today, FDA approved a second COVID-19 vaccine for the prevention of #COVID19 disease in individuals 18 years of age and older. fda.gov/news-events/pr…
“The FDA’s approval of (the vaccine) is a significant step in the fight against the COVID-19 pandemic, marking the second vaccine approved to prevent COVID-19.” – Acting FDA Commissioner @DrWoodcockFDA
“Safe and effective vaccines are our best defense against the COVID-19 pandemic, including currently circulating variants. The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous scientific standards.” – @FDACBER Director Dr. Peter Marks
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(